Nymox Pharmaceutical Corp NYMXF
$0.00
Last Updated: Aug 20, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
NYMXF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Nymox Pharmaceutical Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Nymox Pharmaceutical Corp. Stock Analysis NYMXF
United States Health Care Nano Cap Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. The company is headquartered in Saint-Laurent, Quebec. The firm is focused on developing its drug candidate, Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The firm also has a patent portfolio covering its marketed products, its investigational drugs, as well as other therapeutic and diagnostic indications. The company also has the United States and global patent rights for the use of statin drugs for the treatment and prevention of Alzheimer’s disease. Its products also include NicAlert and TobacAlert. NicAlert is a simple test to determine smoking status. The company is an easy-to-read test strip that can be used with either a saliva or a urine sample. TobacAlert is a home test that provides a quick, accurate, on-the-spot determination of a person’s level of exposure to tobacco products, including second-hand smoke.
Nymox Pharmaceutical Corp (NYMXF) Chart
Financial Metrics & Statements of Nymox Pharmaceutical Corp (NYMXF)
FAQ's for Nymox Pharmaceutical Corp (NYMXF)
- As of August 2026, Nymox Pharmaceutical Corp NYMXF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nymox Pharmaceutical Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Nymox Pharmaceutical Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Nymox Pharmaceutical Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Nymox Pharmaceutical Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Nymox Pharmaceutical Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Nymox Pharmaceutical Corp (NYMXF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
